MOLLY SVEC: Open Payments
NPI 1578148839 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 22 payments from 11 companies in 2025. Trend: 2023 $339 · 2024 $438 · 2025 $526
Food & beverage: $426Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $100 |
| Amgen Inc. | 4 | $76 |
| ABBVIE INC. | 3 | $69 |
| LEO Pharma Inc. | 3 | $67 |
| UCB, Inc. | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Botanix SB Inc | 2 | $36 |
| PFIZER INC. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $21 |
Products named: TREMFYA, Otezla, SKYRIZI, ADBRY, Bimzelx, Zoryve, SOFDRA, COSENTYX.
Industry payments across NE — which companies pay providers there.
